These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25393617)

  • 21. A menu-driven software package of Bayesian nonparametric (and parametric) mixed models for regression analysis and density estimation.
    Karabatsos G
    Behav Res Methods; 2017 Feb; 49(1):335-362. PubMed ID: 26956682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variance components analysis for pedigree-based censored survival data using generalized linear mixed models (GLMMs) and Gibbs sampling in BUGS.
    Scurrah KJ; Palmer LJ; Burton PR
    Genet Epidemiol; 2000 Sep; 19(2):127-48. PubMed ID: 10962474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian analysis of multi-type recurrent events and dependent termination with nonparametric covariate functions.
    Lin LA; Luo S; Chen BE; Davis BR
    Stat Methods Med Res; 2017 Dec; 26(6):2869-2884. PubMed ID: 26546256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data.
    Zhang Z; Sinha S; Maiti T; Shipp E
    Stat Methods Med Res; 2018 Apr; 27(4):971-990. PubMed ID: 28034170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian adaptive group lasso with semiparametric hidden Markov models.
    Kang K; Song X; Hu XJ; Zhu H
    Stat Med; 2019 Apr; 38(9):1634-1650. PubMed ID: 30484887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian semiparametric failure time models for multivariate censored data with latent variables.
    Ouyang M; Wang X; Wang C; Song X
    Stat Med; 2018 Dec; 37(28):4279-4297. PubMed ID: 30101485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalized linear mixed hidden semi-Markov models in longitudinal settings: A Bayesian approach.
    Haji-Maghsoudi S; Bulla J; Sadeghifar M; Roshanaei G; Mahjub H
    Stat Med; 2021 May; 40(10):2373-2388. PubMed ID: 33588516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing variational Bayes with Markov chain Monte Carlo for Bayesian computation in neuroimaging.
    Nathoo FS; Lesperance ML; Lawson AB; Dean CB
    Stat Methods Med Res; 2013 Aug; 22(4):398-423. PubMed ID: 22642986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian adaptive lasso for additive hazard regression with current status data.
    Wang C; Li Q; Song X; Dong X
    Stat Med; 2019 Sep; 38(20):3703-3718. PubMed ID: 31197854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A random-censoring Poisson model for underreported data.
    de Oliveira GL; Loschi RH; Assunção RM
    Stat Med; 2017 Dec; 36(30):4873-4892. PubMed ID: 29067731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimations of competing lifetime data from inverse Weibull distribution under adaptive progressively hybrid censored.
    Azm WSAE; Aldallal R; Aljohani HM; Nassr SG
    Math Biosci Eng; 2022 Apr; 19(6):6252-6275. PubMed ID: 35603400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations.
    Paul M; Riebler A; Bachmann LM; Rue H; Held L
    Stat Med; 2010 May; 29(12):1325-39. PubMed ID: 20101670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invited commentary: Lost in estimation--searching for alternatives to markov chains to fit complex Bayesian models.
    Molitor J
    Am J Epidemiol; 2012 Mar; 175(5):376-8; discussion 379-80. PubMed ID: 22306561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binary regression with misclassified response and covariate subject to measurement error: a bayesian approach.
    McGlothlin A; Stamey JD; Seaman JW
    Biom J; 2008 Feb; 50(1):123-34. PubMed ID: 18283683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian mixed-effects location and scale models for multivariate longitudinal outcomes: an application to ecological momentary assessment data.
    Kapur K; Li X; Blood EA; Hedeker D
    Stat Med; 2015 Feb; 34(4):630-51. PubMed ID: 25409923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulation-based estimators of analytically intractable causal effects.
    Linero AR
    Biometrics; 2022 Sep; 78(3):1001-1017. PubMed ID: 34051105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian propensity score analysis for observational data.
    McCandless LC; Gustafson P; Austin PC
    Stat Med; 2009 Jan; 28(1):94-112. PubMed ID: 19012268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variational methods for fitting complex Bayesian mixed effects models to health data.
    Lee CY; Wand MP
    Stat Med; 2016 Jan; 35(2):165-88. PubMed ID: 26415742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining parametric and nonparametric models to estimate treatment effects in observational studies.
    Daly-Grafstein D; Gustafson P
    Biometrics; 2023 Sep; 79(3):1986-1995. PubMed ID: 36250351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.